MENU

Lori Goldstein, MD, FASCO

Lori Goldstein, MD, FASCO

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Director, The Naomi and Phil Lippincott Breast Evaluation Center

Deputy Associate Director, Clinical Research

Professor, Department of Hematology/Oncology

Breast Cancer TRDG Member

NCCN, Breast Cancer Panel Member

Specialties

Treatment Focus

  • Systemic chemotherapy, hormonal therapy and biologic therapy for early and advanced stage breast cancer
  • Clinical and translational trials in breast cancer

Research Program

Key Awards

Philadelphia Magazine Top Docs 2018
Medical Oncology

Treatment Philosophy

As a medical oncologist specializing in breast cancer, I believe in providing women the most tailored, state-of-the-art treatment options. That is why I created the Breast Evaluation Center (BEC) when I joined the staff at Fox Chase Cancer Center in 1990.

As the director of the BEC, I work with a team of breast cancer experts, including medical oncologists, surgical oncologists, radiation oncologists, radiologists, pathologists and social workers. Together, we develop a comprehensive treatment plan for patients with early stage breast cancer.

By providing patients with useful information about their treatment options, we are empowering them with the knowledge to make informed decisions about their care. I believe this is very important for women who have been diagnosed with breast cancer, as they can be overwhelmed with the amount of information available today... Expand

Education and Training

Educational Background

  • Fellow, Oncology, Division of Cancer Treatment and Division of Cancer Biology and Diagnosis, National Cancer Institute, Washington, DC
  • Resident, Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • MD, State University of New York Upstate College of Medicine, Syracuse, NY, 1982

Certifications

  • American Board of Internal Medicine
  • Internal Medicine
  • Medical Oncology

Memberships

  • National Comprehensive Cancer Network (NCCN)
    • Breast Cancer Panel
  • Program Director, Breast Cancer Symposium, Fox Chase Cancer Center
  • Course Director, Fox Chase Cancer Center Highlights of SABCS CME Program
  • American Association for the Advancement of Science
  • American Association of Cancer Research
  • American Society of Clinical Oncology
  • National Accreditation Program for Breast Cancer Centers
  • Women in Cancer Research

Honors & Awards

  • Philadelphia magazine Top Doctors, 2009-18
  • Forbes Magazine list of 27 Top Breast Cancer Oncologists, 2017
  • America’s Top Doctors®,  2012-2017
  • Best Doctors in America®, 2013-15
  • Susan G. Komen "Light of Life Award,” 2014
Patient Stories

Karen Lucas

Breast Cancer

Karen Lucas

Breast Cancer

For more than 20 years, Karen Lucas has been diligent about getting annual mammograms, as well as yearly visits to her OB/GYN. At the age of 65, during a routine mammogram in August 2012, the test showed calcification in both breasts.

Patti Rose

Breast Cancer

Patti Rose

Breast Cancer

At 36, Patti Rose, a wife and mother to seven children, was shocked to learn she had a rare form of breast cancer. Because her husband works in construction and had done several projects for Fox Chase Cancer Center, they knew right away Fox Chase was the right place for Patti's treatment. At Fox Chase, Patti underwent chemotherapy and radiation therapy, followed by a lumpectomy and additional surgery. The experience was extremely difficult, but Patti credits the staff at Fox Chase for giving her a positive outlook and helping her get through it. Today, she is cancer free and could not be more pleased with the treatment she received. "Fox Chase helped me to be positive. If I didn’t have that connection with doctors and nurses and even the security guard that I would talk to every time I was there, I think I would have felt more afraid," she said. "Knowing all those people were praying for me, thinking of me, and trying to get me through it made me feel like I could overcome it."

Laura Marblestone

Breast Cancer

Laura Marblestone

Breast Cancer

Because Laura Marblestone's mother lost her fight with breast cancer at the age of 43, Laura regularly performed breast self-exams. In 1991, she was diagnosed with encapsulated metastatic carcinoma, and a friend recommended she seek treatment at Fox Chase Cancer Center. After a mestectomy and a round of chemotherapy, Laura was considered cancer free, but in 2006, she found a lump in her right breast; the cancer had returned. She underwent a second mastectomy, chemotherapy, and breast reconstructive surgery. "Even though it took me three months to recover, I would do it again in a heartbeat," she said. "The doctors at Fox Chase were thorough--they didn't leave a stone unturned."

Shari Lynn

Breast Cancer

Shari Lynn

Breast Cancer

In 2002, Shari Lynn's husband, Mark, accepted a new job in another state. Together, Shari and Mark made the decision to move their family from New York to Pennsylvania. Shari was like many other moms in her situation. In preparing for the move, she scheduled routine doctor appointments on Long Island so they would not feel pressured to find new physicians right away.

Robin Luber

Breast Cancer

Robin Luber

Breast Cancer

If you have a question about Fox Chase Cancer Center, ask Robin Luber. She spends every Wednesday volunteering at Fox Chase so you are likely to see her walking the halls helping patients and families or in the Family Surgical Waiting Lounge. She also volunteers in Social Services assisting the social workers with administrative tasks. "I love this job," shared Robin. "I help patients, their families, and the staff. It's very rewarding." And that's coming from a former patient.

Pages

Research Profile

Research Program

Research Interests

  • Translational studies in breast cancer
  • Development of novel therapeutic strategies in breast cancer
  • Molecular targeting of breast cancer
Publications

Selected Publications

Goldstein, LJ, Gray, R, Badve, S, Childs, BH, Yoshizawa, C, Rosley, S, Shak, S, Baehner, FL, Ravdin PM, Davidson, NE, Sledge, GW, Perez, E, Shulman, LN, Martino, S, Sparano, JA: Prognostic Utility of the 21-Gene Assay in Hormone Receptor Positive Operable Breast Cancer with Classical Prognostic Factors and an Integrator of Classical Clinicopathologic and Treatment Information.  JCO, Vol. 26, No. 25, Pg. 4063, September 2, 2008. PubMed

Goldstein, L.J., O’Neill, A., Sparano, J.A., Perez, E.A., Shulman, L.N., Martino, S.,Davidson, N.: Concurrent doxorubicin plus doxetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0-3 positive axillary nodes: results of North American Breast Cancer Intergroup Trial E2197. JCO, Vol. 26, No. 25, Pg. 4092, September 2, 2008. PubMed

Finn, RS, Bengala, C, Strauss, LC, Fairchild, J, Sy, O, Ibrahim, N, Rouche, H, Sparano, J, Goldstein, LJ.:  Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study.  Clin Cancer Res. 2011 Nov 1;17(21):6905-13.

Tevaarwerk AJ, Gray R, Schneider BP, Smith ML, Wagner LI, Fetting J, Davidson N, Goldstein LJ, Miller KD, Sparano JA. Survival in Metastatic Recurrent Breast Cancer after Adjuvant Chemotherapy: Little Evidence for Improvement Over the Past Three Decades. Cancer. 2013 Mar;119(6):1140-8.   PMCID: 3593800

Goldstein, LJ, Tosello-Oliveria, C, Heinrich B, Stemmer SM, Mala C, Kastner S, Bevan P Richters L, Schmalfeldt B, Harbeck N.  A Randomized double-blind phase II study of the combination of oral WX-671 plus capecitabine vs capecitabine monotherapy in first-line HER2-negative metastatic breast cancer (MBC). ASCO 2013 Oral presentation, J. Clin Oncol 31, suppl; Abstract 508.

Goldstein LJ, Gurtler J, Del Prete SA, Tjulandin S, Semiglazov VF, Bayever E, Michiels B. Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens.  Clinical Breast Cancer, 14(6):396-404, 2014.

Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, Anderson PR, Sigurdson ER, Goldstein LJ, Bleicher RJ.: Risk of Positive Nonsentinel Nodes in Women with 1-2 Positive Sentinel Nodes Related to Age and Molecular Subtype Approximated by Receptor Status.  Breast J Vol. 20(4) 358-363, July 2014. PubMed

Adams S, Gray RJ, Demaria S, Goldstein LJ, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ,  Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SS.: Prognostic Value of Tumor-Infiltrating Lymphocytes (TILs) in Triple Negative Breast Cancers (TNBC) from two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199.  J Clin Oncol 2014 Sept 20; 32(27):2959-67.  PMID: 25513417.

Silverman, D, Ruth, KJ, Sigurdson, E, Egleston, BL, Goldstein, LJ, Boraas, M, Bleicher R.:  Skin Involvement and Breast Cancer: Are T4b Lesions of All Sizes Created Equal?  Journal of the American College of Surgeons.   Vol 219(3) 534-544 September 2014. PMCID: 4143438.

Matro J, Walia R, Tumelty K, Morrison T, Goldstein LJ.: Bilateral Hypoglossal Nerve Palsy Due to Breast Cancer Skull Base Metastases.  AJHO Vol 10(5) 14-16, Nov. 2014.

Additional Publications

My NCBI

Ratings

45 PATIENT SATISFACTION REVIEWS

Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

OVERALL RATING

4.9 / 5.0

RATINGS BREAKDOWN

  • 4.9
  • 4.8
  • 5.0
  • 5.0
  • 4.8

4 PATIENT COMMENTS

  • 4.5
    August 30, 2018
    Dr Goldstein is awesome.
  • 5.0
    July 09, 2018
    Dr. Goldstein is a very caring knowledgeable dr.
  • 5.0
    June 18, 2018
    Always great.
  • 5.0
    May 31, 2018
    I spend more time w/ fellow but feel confident Dr. G is involved, overseeing. She has softened up in the past few months. Used to be very clinical but shows a person side now _____ I feel good about the advice/direction.
LOAD MORE

Connect with Fox Chase